SOPH
Income statement / Annual
Last year (2025), SOPHiA Genetics SA's total revenue was $77.27 M,
an increase of 18.56% from the previous year.
In 2025, SOPHiA Genetics SA's net income was -$79.00 M.
See SOPHiA Genetics SA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$77.27 M |
$65.17 M |
$62.37 M |
$47.56 M |
$40.45 M |
$28.40 M |
$25.36 M |
| Cost of Revenue |
$29.46 M
|
$21.24 M
|
$19.46 M
|
$16.31 M
|
$15.23 M
|
$10.71 M
|
$7.53 M
|
| Gross Profit |
$47.81 M
|
$43.94 M
|
$42.91 M
|
$31.25 M
|
$25.22 M
|
$17.69 M
|
$17.83 M
|
| Gross Profit Ratio |
0.62
|
0.67
|
0.69
|
0.66
|
0.62
|
0.62
|
0.7
|
| Research and Development Expenses |
$33.57 M
|
$34.37 M
|
$36.97 M
|
$35.37 M
|
$26.58 M
|
$18.59 M
|
$15.02 M
|
| General & Administrative Expenses |
$0.00
|
$46.95 M
|
$53.30 M
|
$55.82 M
|
$41.51 M
|
$18.97 M
|
$15.67 M
|
| Selling & Marketing Expenses |
$0.00
|
$29.37 M
|
$28.42 M
|
$28.27 M
|
$28.74 M
|
$17.43 M
|
$19.41 M
|
| Selling, General & Administrative Expenses |
$85.17 M
|
$76.32 M
|
$81.72 M
|
$84.08 M
|
$70.24 M
|
$36.40 M
|
$35.08 M
|
| Other Expenses |
$0.00
|
-$183.00 K
|
-$954.00 K
|
-$377.00 K
|
-$108.00 K
|
$93.00 K
|
$16.00 K
|
| Operating Expenses |
$118.74 M
|
$110.51 M
|
$117.74 M
|
$119.08 M
|
$96.71 M
|
$55.08 M
|
$50.12 M
|
| Cost And Expenses |
$148.20 M
|
$131.74 M
|
$137.20 M
|
$135.38 M
|
$111.94 M
|
$65.79 M
|
$57.65 M
|
| Interest Income |
$1.87 M
|
$3.36 M
|
$4.55 M
|
$1.32 M
|
$20.00 K
|
$96.00 K
|
$86.00 K
|
| Interest Expense |
$4.55 M
|
$1.91 M
|
$588.00 K
|
$639.00 K
|
$658.00 K
|
$840.00 K
|
$976.00 K
|
| Depreciation & Amortization |
$9.53 M
|
$8.60 M
|
$8.34 M
|
$5.57 M
|
$3.61 M
|
$2.39 M
|
$1.91 M
|
| EBITDA |
-$61.40 M |
-$50.76 M |
-$69.57 M |
-$81.38 M |
-$69.24 M |
-$38.00 M |
-$30.74 M |
| EBITDA Ratio |
-0.79
|
-0.78
|
-1.12
|
-1.71
|
-1.71
|
-1.34
|
-1.21
|
| Operating Income Ratio |
-0.92
|
-1.02
|
-1.2
|
-1.85
|
-1.77
|
-1.32
|
-1.27
|
| Total Other Income/Expenses Net |
-$7.56 M
|
$5.30 M
|
-$3.67 M
|
$238.00 K
|
-$2.02 M
|
-$3.84 M
|
-$1.34 M
|
| Income Before Tax |
-$78.49 M
|
-$61.27 M
|
-$78.50 M
|
-$87.59 M
|
-$73.51 M
|
-$41.23 M
|
-$33.63 M
|
| Income Before Tax Ratio |
-1.02
|
-0.94
|
-1.26
|
-1.84
|
-1.82
|
-1.45
|
-1.33
|
| Income Tax Expense |
$512.00 K
|
$1.22 M
|
$486.00 K
|
-$136.00 K
|
$168.00 K
|
-$1.89 M
|
$162.00 K
|
| Net Income |
-$79.00 M
|
-$62.49 M
|
-$78.98 M
|
-$87.45 M
|
-$73.68 M
|
-$39.34 M
|
-$33.79 M
|
| Net Income Ratio |
-1.02
|
-0.96
|
-1.27
|
-1.84
|
-1.82
|
-1.39
|
-1.33
|
| EPS |
-1.17 |
-0.95 |
-1.22 |
-1.36 |
-1.33 |
-0.82 |
-0.53 |
| EPS Diluted |
-1.17 |
-0.95 |
-1.22 |
-1.36 |
-1.33 |
-0.82 |
-0.53 |
| Weighted Average Shares Out |
$67.54 M
|
$65.78 M
|
$64.75 M
|
$64.10 M
|
$55.30 M
|
$48.02 M
|
$63.86 M
|
| Weighted Average Shares Out Diluted |
$67.54 M
|
$65.78 M
|
$64.75 M
|
$64.10 M
|
$55.30 M
|
$48.02 M
|
$63.86 M
|
| Link |
|
|
|
|
|
|
|
